Robert Baranello, MD
Pain Medicine · Durham, NCNPI 1457848301
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,261 of the $4,993 with a category attached, or 65.3%. 11 manufacturers reported payments, led by Medtronic at 51.7% of the total. Reporting peaked in 2024 at $2,965 and has fallen 71.1% since, to $857 in 2025.
Across 53 payments — averaging $94.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$2K
- Nevro Corp.$340
- Saluda Medical Americas, Inc.$159
- SPR Therapeutics, Inc$151
- Si-bone, Inc.$69
- plus $90 from 5 others
What the payments were for
- Travel & lodging$1,73235%
- Food & beverage$3,26165%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 26 | $2,583 |
| Boston Scientific | 14 | $1,600 |
| Nevro Corp. | 4 | $340 |
| Saluda Medical Americas, Inc. | 1 | $159 |
| SPR Therapeutics, Inc | 2 | $151 |
| Si-bone, Inc. | 1 | $69 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Averitas Pharma Inc. | 1 | $18 |
| Bioventus LLC | 1 | $18 |
| Abbott | 1 | $17 |
| Avanos Medical | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$1,662
- Intracept$1,167
- INCEPTIV$291
- Senza$233
- Evoke$159
- KYPHON EXPRESS II KYPHOPAK TRAY$125
How this compares
$4,993 in reported general payments places this provider in the 55th percentile of 182 pain medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 23 | $10,276 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 73 | $2,644 |
| Lidocaine | 25 | $1,986 |
| Diclofenac Sodium | 26 | $1,509 |
| Gabapentin | 99 | $1,234 |
| Celecoxib | 35 | $592 |
| Tramadol Hcl | 99 | $449 |
| Methocarbamol | 39 | $428 |
| Oxycodone Hcl | 28 | $410 |
| Pregabalin | 34 | $407 |
| Chlorzoxazone | 11 | $372 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $344 |
| Tizanidine Hcl | 23 | $248 |
| Cyclobenzaprine Hcl | 17 | $191 |
| Meloxicam | 31 | $170 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Durham
- Richard Boortz-MarxDurham$19K
- James NorthWinston Salem$721K
- Leonardo KapuralWinston Salem$523K
- Christopher GilmoreWinston Salem$457K
- Richard RauckWinston Salem$431K
- Courtney AumanJacksonville$186K
- Jacob WangCharlotte$162K
- Aashish KumarCharlotte$160K
- Javid BakshAsheville$116K
- David ZubLeland$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.